Michael James Austin (Michael J Austin)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Health Information

Chemotherapy Induced

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Vilma Dembitz, Hannah Lawson, Richard Burt, Sirisha Natani, Céline Philippe, Sophie C James, Samantha Atkinson, Jozef Durko, Lydia M Wang, Joana Campos, Aoife M S Magee, Keith Woodley, Michael James Austin, Ana Rio-Machin, Pedro Casado, Findlay Bewicke-Copley, Giovanny Rodriguez Blanco, Diego Pereira-Martins, Lieve Oudejans, Emeline Boet, Alex von Kriegsheim, Juerg Schwaller, Andrew J Finch, Bela Patel, Jean-Emmanuel Sarry, Jerome Tamburini, Jan Jacob Schuringa, Lori Hazlehurst, John A Copland Iii, Mariia Yuneva, Barrie Peck, Pedro Rodriguez Cutillas, Jude Fitzgibbon, Kevin Rouault-Pierre, Kamil R Kranc, Paolo Gallipoli
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation. Leukemia (2024)
Michael James Austin, Foteini Kalampalika, William P Cawthorn, Bela Patel
Turning the spotlight on bone marrow adipocytes in haematological malignancy and non-malignant conditions. British journal of haematology (2023)
Jad Othman, Ing Soo Tiong, Jenny O'Nions, Mike Dennis, Katya Mokretar, Adam Ivey, Michael James Austin, Annie-Louise Latif, Mariam Amer, Wei Yee Chan, Charles R Crawley, Francesca Crolla, Joe Wilson Cross, Raymond Dang, Johnathon Elliot, Chun Yew Fong, Sofia Galli, Paolo Gallipoli, Francesca Hogan, Pallavi Kalkur, Anjum Bashir Khan, Pramila Krishnamurthy, John Laurie, Sun Loo, Scott Marshall, Priyanka Mehta, Vidhya Murthy, Sateesh K Nagumantry, Srinivas Pillai, Nicola Potter, Rob S Sellar, Thomas Taylor, Rui Zhao, Nigel H Russell, Andrew H Wei, Richard Dilon
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based non-intensive therapy. Blood (2023)
Antonella Di Mambro, Yoana Arroyo-Berdugo, Tiziana Fioretti, Michael Randles, Luca Cozzuto, Vinothini Rajeeve, Armando Cevenini, Michael James Austin, Gabriella Esposito, Julia Ponomarenko, Claire M Lucas, Pedro Rodriguez Cutillas, John G Gribben, Owen Williams, Yolanda Calle, Bela Patel, Maria Teresa Esposito
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML. Oncogene (2023)